More than 300 GPs have withdrawn from partnerships with Virgin Care due to a potential conflict of interest between their provider and commissioner roles.

The Medical Research Council (MRC) has committed £7m funding to support 15 academic drug research projects using compounds from AstraZeneca.

Major pharma companies are paying multi-million dollar fines for alleged bribery in emerging markets, but these markets remain highly profitable.

NICE has reversed its original decision on the use of Pharmaxis’ Bronchitol and now backs the use of the mannitol dry powder for treating cystic fibrosis in certain adult patients.

Widely prescribed drugs including insulin, warfarin and aspirin are less effective in patients who take herbal medicines and dietary supplements.

Dr Tonio Borg looks set to take over as European Commissioner for Health and Consumer Affairs following John Dalli’s resignation from the post in mid-October.

New research by UK scientists has identified distinct cell types that may be responsible for pre- and post-menopausal breast cancers.

Two Novartis vaccines for seasonal influenza have been temporarily banned in six EU countries due to a suspected quality fault. Batches of Agrippal and Fluad were reported by the company to contain...

Cancer patients whose disease has spread from a solid tumour to their bones have now been given a new treatment option after NICE backed the use of Amgen’s Xgeva (denosumab).

NICE has recommended the use of Novartis’ Tobi Podhaler tablets but failed to back Forest Laboratories UK’s Colobreathe tablets for treating cystic fibrosis patients with a pseudomonas lung infection.